Chemcrux Enterprises has received in-principal approval from board of directors of the company to acquire and/or subscribe 5000 equity shares of Rs 10 each (50%) of Kalichem. On completion of the proposed acquisition, Kalichem will be classified as a Wholly Owned Subsidiary Company and will no longer be considered as a Joint Venture Company.
The business is in same line as that of the main line of business of the listed entity. The proposed acquisition is expected to be completed before March 31, 2025, subject to compliance with stipulations, consents and necessary approvals.
Chemcrux Enterprises is engaged in high pressure Oxidation, Chlorosulfonation, Nitration and Aceylation forb manufacturing of intermediates for bulk drugs, dyes and pigments.
| Company Name | CMP |
|---|---|
| BASF India | 3667.90 |
| Tata Chemicals | 704.95 |
| SRF | 2461.50 |
| Pidilite Inds. | 1393.60 |
| Deepak Nitrite | 1543.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: